Main Board • Is Vilitra 60 Mg a phosphodiesterase type 5 inhibitor?

---

29.03.2024, 12:21 - joniscosttale - - 25 Beiträge Vilitra 60 mg contains vardenafil, which is a phosphodiesterase type 5 (PDE5) inhibitor. Vardenafil works by inhibiting the action of the enzyme phosphodiesterase type 5, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the penis. During sexual stimulation, nitric oxide is released in the erectile tissue of the penis, which activates the enzyme guanylate cyclase. This leads to an increase in levels of cGMP, which causes relaxation of the smooth muscles in the penile arteries and corpus cavernosum, allowing increased blood flow into the penis and resulting in an erection. By inhibiting the action of PDE5, vardenafil helps to prolong the effects of nitric oxide and cGMP, leading to enhanced erectile function and improved ability to achieve and maintain an erection. Vilitra 60mg is used to treat erectile dysfunction (ED) in men, which is the inability to achieve or sustain an erection sufficient for satisfactory sexual performance. It's important to note that Vilitra 60 mg should be taken as directed by a healthcare provider and should not be used without a prescription. Additionally, vardenafil, like other PDE5 inhibitors, is not a cure for erectile dysfunction and does not increase sexual desire. It works only in the presence of sexual stimulation to produce an erection.